---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024717"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2023-07-17T23:59:59+00:00"
generated_at: "2026-06-13T07:42:19.265586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Evofem Biosciences dismisses Deloitte, appoints BPM as auditor; reduces stockholder quorum to one-third

## Summary
- Dismissed Deloitte & Touche as auditor effective July 11, 2023; no disagreements but prior reports included going-concern qualification.
- Appointed BPM LLP as new independent auditor, subject to stockholder ratification at 2023 Annual Meeting.
- Previously disclosed material weaknesses in internal control over financial reporting as of Dec 31, 2022.
- Amended bylaws to reduce quorum requirement for stockholder meetings from majority to one-third of outstanding shares.
- Removed requirement for Board consent to reschedule annual meeting.

## SEC filing metadata
- accession: 0001493152-23-024717
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2023-07-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.03, 5.03, 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/0001493152-23-024717-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024717
- JSON: https://secwatch.observer/filing/0001493152-23-024717.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024717.txt

## Key facts
- Auditor Changes
  Evofem Biosciences, Inc. dismissed Deloitte & Touche LLP as its auditor.
  - Action: dismissal
  - Auditor: Deloitte & Touche LLP
  - Successor: BPM LLP
  source text: the Audit Committee recommended, and the Board approved the dismissal of Deloitte & Touche LLP ("Deloitte"), as the Company's independent registered public accounting firm, on July 11, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/0001493152-23-024717-index.htm
- Auditor Changes
  Evofem Biosciences, Inc. engaged BPM LLP as its auditor.
  - Action: engagement
  - Auditor: BPM LLP
  source text: On July 11, 2023, the Company appointed BPM LLP ("BPM") as the Company's new independent registered public accounting firm effective as of July 11, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/0001493152-23-024717-index.htm
- Governance Changes
  Evofem Biosciences, Inc.: Amended and restated bylaws to remove requirement for Board consent to reschedule annual meeting and reduce quorum from a majority to one-third (effective 2023-07-11).
  - Change: bylaw amendment
  - Effective: 2023-07-11
  source text: On July 11, 2023, the board of directors the (“Board”) of Evofem Biosciences, Inc. (the “Company”), adopted and approved an amendment and restatement of the Company’s Amended and Restated Bylaws (the “Second Amended and Restated Bylaws”) in order to change, among other things: ● Section 2, removing requirement for Board Consent to reschedule annual meeting ● Section 3, so the proportion of shares present required to constitute a quorum at a meeting of stockholders, from a majority to one-third of the outstanding shares of stock entitled to vote, as permitted under § 216 of the Delaware General Corporation Law.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/0001493152-23-024717-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.